Cowealth Medical Holding Co., Ltd. (4745) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cowealth Medical Holding Co., Ltd. (4745:TWSE), powered by AI.

Current Price
$14.60
P/E Ratio
-4.6
Market Cap
1.1B
Sector
Healthcare
What is the Cowealth Medical Holding Co., Ltd. stock price forecast?

Cowealth Medical Holding Co., Ltd. is currently trading at $14.60. View real-time AI analysis on Alpha Lenz.

What is Cowealth Medical Holding Co., Ltd. insider trading activity?

View the latest insider trading data for Cowealth Medical Holding Co., Ltd. on Alpha Lenz.

What is Cowealth Medical Holding Co., Ltd.'s P/E ratio?

Cowealth Medical Holding Co., Ltd.'s P/E ratio is -4.6.

Cowealth Medical Holding Co., Ltd.

TWSE · 4745
NT$14.60+0.10(+0.69%)
Ask about Cowealth Medical Holding Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Cowealth Medical Holding Co., Ltd. trades at a P/E of -4.6 (undervalued) with modest ROE of -8.7%.

Ask for details

Company Overview

Cowealth Medical Holding Co., Ltd. is a holding company specializing in the manufacture and distribution of advanced medical equipment, devices, and related products. Its primary purpose is to provide innovative healthcare solutions across Greater China, serving hospitals and clinical laboratories with a focus on cancer treatment systems, in-vitro diagnostic reagents, and high-end clinical testing technology. The company’s portfolio includes notable devices such as the CyberKnife Stereotactic Radiosurgery System for radiation therapy and the MRIdian-Linac MRI-guided system, as well as comprehensive diagnostic tools and reagents. Beyond direct product distribution, Cowealth Medical Holding Co., Ltd. supports the healthcare sector through digital innovations, including platforms for management analysis, multi-channel audio-video imaging, and AI-assisted clinical decision support, all designed to enhance medical resource efficiency and hospital competitiveness. With operations in Taiwan, China, and Hong Kong, Cowealth Medical Holding Co., Ltd. plays a significant role in elevating healthcare standards by bridging technological advancements and tailored service models in the rapidly evolving healthcare industry.

CEOMr. Duane Lee
SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

NT$1.13BMarket Cap
NT$2.96BRevenue
0.00Shares Out
0Employees

Margins

13.27%Gross
-3.99%EBITDA
-6.07%Operating
-9.65%Pre-Tax
-11.20%Net

Valuation

-4.59P/E
0.39P/B
0.38EV/Sales
-28.71EV/EBITDA
1354.06P/FCF

Growth (CAGR)

-19.31%Rev 3Yr
-8.94%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-4.73%ROA
-8.70%ROE
-3.75%ROIC

Financial Health

NT$943.50MCash & Cash Equivalents
NT$1.04BNet Debt
39.26%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cowealth Medical Holding Co., Ltd. (ticker: 4745) is a company listed on TWSE in the Healthcare sector (Medical Devices). Market cap is $1.1B.

The current price is 14.6 with a P/E ratio of -4.59x and P/B of 0.39x.

ROE is -8.70% and operating margin is -6.07%. Annual revenue is $3.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cowealth Medical Holding Co., Ltd. (4745) Stock Forecast 2026 $14.60 — Price, Financials & Analyst Targets | Alpha Lenz